Johns Hopkins University has launched an ambitious endeavor that the school’s leaders say will make Baltimore a hub of the…
AndyJanuary 30, 2024
ROCKVILLE, Md., Jan. 29, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it…
AndyJanuary 29, 2024
Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…
adminJanuary 26, 2024
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused…
AndyJanuary 23, 2024
After a period of leadership transition and strategic planning, the organizations behind one of Baltimore’s longest-standing entrepreneurial communities have appointed…
AndyJanuary 23, 2024
BALTIMORE, Jan. 22, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company and developer of best-in-class personalized MRD technology (Haystack MRD™),…
AndyJanuary 23, 2024
January 16, 2024 - By Laura Lee - Principal Investigator Robert K. Ernst, PhD, the Dr. Paul and Mrs. Jean Corcoran Endowed Professor and chair of…
AndyJanuary 22, 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology…
AndyJanuary 19, 2024
Tiffany Yesavage, PhD - January 11, 2024 - The use of artificial intelligence (AI) to develop new drugs is in its infancy.…
AndyJanuary 19, 2024